Menu
Strategy
Team
Portfolio
News
Careers
Contact
News
Home
/
News
In the News
OCV Partners Assist Portfolio Company Social Native in Acquiring Olapic to Create Next-Gen Creative Optimization Platform
September 29, 2020
OCV Partners Participates in Finch Therapeutics’ Oversubscribed $90 Million Financing to Advance its Pipeline of Investigational Oral Microbiome Drugs
September 17, 2020
SafeBreach Raises $19 Million to Expand Channels, Accelerate Product Development
April 16, 2020
OCV Partners Co-leads By Heart’s $70M Series A Financing Ahead of First Product Launch in 2021
April 14, 2020
OSSIO Receives FDA 510(k) Clearance for OSSIOfiber
®
Hammertoe Fixation System
March 12, 2020
Finch Therapeutics Completes Enrollment in Potentially Pivotal Trial of CP101, an Investigational Oral Full-Spectrum Microbiota
®
Therapy for the Prevention of Recurrent C. difficile Infection
January 8, 2020
Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies for Recurrent C. Difficile, Autism and other Disease Areas
August 26, 2019
Museum of Ice Cream Founders Launch Figure8 with Series A to Transform How Millennials and Gen-Z Connect With Spaces and Each Other
August 14, 2019
OSSIO Secures $22 Million in Financing
March 11, 2019
Invoice2go Raises $10 Million, Attracting New and Existing Investors, and Hemi Zucker from OCV Partners to join the Board of Directors
September 12, 2018
Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs
June 26, 2018
Hemi Zucker to Join OCV Management as Managing Principal
September 28, 2017
